ITRM
NASDAQ
IE
Iterum Therapeutics plc - Ordinary Share
$0.03
▲ +$0.00
(+0.00%)
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$17.7M
ROE
-216.4%
Margin
-2302.3%
D/E
576.47
Beta
3.00
52W
$0–$2
Wall Street Consensus
8 analysts · Mar 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%
Next Report
May 11, 2026
EPS Estimate: $-0.10
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.10 | — | — |
| Sep 2025 | $-0.11 | $-0.20 | $-0.09 |
| Jun 2025 | $-0.11 | $-0.16 | $-0.05 |
| Mar 2025 | $-0.15 | $-0.14 | +$0.01 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $390K |
| Net Income | -$6.1M | -$6.6M | -$4.9M | -$6.5M | -$9.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -216.3% | -216.3% | -216.3% | -216.3% | -216.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -11875.0% | -11875.0% | -11875.0% | -11875.0% | -2302.3% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 576.47 | 576.47 | 576.47 | 576.47 | 576.47 |
| Current Ratio | 2.69 | 2.71 | 2.69 | 2.69 | 2.69 | 2.13 |
Key Ratios
ROA (TTM)
-74.9%
P/S (TTM)
45.34
P/B
0.4
EPS (TTM)
$-0.75
CF/Share
$-2.30
52W High
$2.10
52W Low
$0.30
$0.30
52-Week Range
$2.10
Financial Health
Free Cash Flow
-$7.5M
Net Debt
$22.7M
Cash
$11.0M
Total Debt
$33.7M
As of Sep 30, 2025
How does ITRM compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
ITRM valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
45.3
▲
816%
above
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0.4
▼
83%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
ITRM profitability vs Pharmaceuticals peers
ROE
-216.4%
▼
299%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-2302.3%
▼
4760%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-74.9%
▼
100%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
ITRM financial health vs Pharmaceuticals peers
D/E ratio
576.5
▲
37333%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
2.1
▼
36%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
3.0
▲
219%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
ITRM fundamentals radar
ITRM
Peer median
Industry
ITRM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ITRM vs peers: key metrics
Latest News
No related news yet